All In Biotech

Drug Trial Radar · NCT04041791

A Study to Compare Different Antibiotics and Different Modes of Fluid Treatment for Children With Severe Pneumonia

Supportive Care and Antibiotics for Severe Pneumonia Among Hospitalized Children (SEARCH): A Pragmatic Randomised Controlled Trial

Last checked: Nov 19, 2026Latest source record: Jul 8, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 4,392 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

4,392

Actual

Start

Aug 19, 2019

Primary completion

Apr 5, 2024

Study completion Apr 5, 2024

Sponsor

Lead sponsor
University of OxfordAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
University of Nairobi; London School of Hygiene and Tropical Medicine; National Institute for Health Research, United Kingdom; Department for International Development, United Kingdom; Medical Research Council; Wellcome Trust; Kenya Ministry of Health
First posted
Aug 1, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Factorial
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 2 months, up to 59 months
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Pneumonia is one of the top causes of death in children aged below 5. More than 10% of children with severe pneumonia die. We are not sure that the currently recommended antibiotics used in children with pneumonia are the most effective. No studies have been carried out to find out whether children with pneumonia should be given intravenous (IV) fluids or nasogastric (NG) feeds. The SEARCH trial aims to find out which antibiotics and modes of feeding are the most effective in treating children with severe pneumonia and therefore helping reduce mortality.

Conditions

  • Pneumonia

Interventions

  • Benzyl penicillinDrug

    Benzyl penicillin is a penicillin antibiotic.

  • Gentamicin SulfateDrug

    Gentamicin is an aminoglycoside antibiotic.

  • CeftriaxoneDrug

    Ceftriaxone is a third generation cephalosporin antibiotic active against a wide range of gram negative and positive bacteria.

  • Amoxicillin ClavulanateDrug

    Amoxicillin Clavulanate is a combination of amoxicillin, a β-lactam antibiotic, and potassium clavulanate, a β-lactamase inhibitor.

  • Intravenous fluidOther

    Maintenance fluids administered for at least 24 hours.

  • Nasogastric feedsOther

    Feeds given via nasogastric tube. Feeds may include cow's milk, breast milk, porridge, formula among others.

  • AmpicillinDrug

    Ampicillin is a penicillin-type antibiotic.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. MortalityTime frame: Up to Day 5

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Machakos Level 5 Hospital

    Machakos, Kenya

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.